Timothy P. Noyes, CHIEF EXECUTIVE OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 1,092 shares at $10.42 ($11K) on 2023-11-01, disclosed to the SEC on 2023-11-03.
Scheduled sale ($11k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AVTE | SELL | 2024-04-18 | $494K | — | Filing → |
| AVTE | SELL | 2024-04-03 | $519K | — | Filing → |
| AVTE | SELL | 2023-08-01 | $99K | — | Filing → |